Vireo Growth Beheer

Beheer criteriumcontroles 2/4

De CEO Vireo Growth is Amber Shimpa, benoemd in Oct2024, heeft een ambtstermijn van minder dan een jaar. De totale jaarlijkse vergoeding van { bedraagt $ 424.24K, bestaande uit 61.3% salaris en 38.7% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.35% van de aandelen van het bedrijf, ter waarde CA$ 401.03K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 0.5 jaar en 5 jaar.

Belangrijke informatie

Amber Shimpa

Algemeen directeur

US$424.2k

Totale compensatie

Percentage CEO-salaris	61.3%
Dienstverband CEO	less than a year
Eigendom CEO	0.3%
Management gemiddelde ambtstermijn	less than a year
Gemiddelde ambtstermijn bestuur	5yrs

Recente managementupdates

Recent updates

Vireo Growth Inc.'s (CSE:VREO) 29% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Oct 12

Vireo Growth Inc. (CSE:VREO) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Aug 10

Market Might Still Lack Some Conviction On Goodness Growth Holdings, Inc. (CSE:GDNS) Even After 30% Share Price Boost

Jun 01

Goodness Growth Holdings, Inc. (CSE:GDNS) Stock Rockets 30% But Many Are Still Ignoring The Company

Apr 06

Investors Still Aren't Entirely Convinced By Goodness Growth Holdings, Inc.'s (CSE:GDNS) Revenues Despite 59% Price Jump

Feb 01

Did Business Growth Power Vireo Health International's (CSE:VREO) Share Price Gain of 127%?

Jan 25

Analyse CEO-vergoeding

Hoe is Amber Shimpa's beloning veranderd ten opzichte van Vireo Growth's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	-US$17m
Jun 30 2024	n/a	n/a	-US$17m
Mar 31 2024	n/a	n/a	-US$24m
Dec 31 2023	US$424k	US$260k	-US$26m
Sep 30 2023	n/a	n/a	-US$34m
Jun 30 2023	n/a	n/a	-US$37m
Mar 31 2023	n/a	n/a	-US$36m
Dec 31 2022	US$759k	US$260k	-US$42m
Sep 30 2022	n/a	n/a	-US$43m
Jun 30 2022	n/a	n/a	-US$41m
Mar 31 2022	n/a	n/a	-US$41m
Dec 31 2021	n/a	n/a	-US$34m
Sep 30 2021	n/a	n/a	-US$22m
Jun 30 2021	n/a	n/a	-US$13m
Mar 31 2021	n/a	n/a	-US$22m
Dec 31 2020	US$231k	US$230k	-US$23m
Sep 30 2020	n/a	n/a	-US$63m
Jun 30 2020	n/a	n/a	-US$78m
Mar 31 2020	n/a	n/a	-US$62m
Dec 31 2019	US$260k	US$260k	-US$57m
Sep 30 2019	n/a	n/a	-US$17m
Jun 30 2019	n/a	n/a	-US$4m
Mar 31 2019	n/a	n/a	-US$4m
Dec 31 2018	US$210k	US$210k	-US$3m
Sep 30 2018	n/a	n/a	-US$2m
Dec 31 2017	US$195k	US$195k	-US$431k

Compensatie versus markt: De totale vergoeding ($USD 424.24K ) Amber } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Canadian markt ($USD 169.25K ).

Compensatie versus inkomsten: De vergoeding van Amber is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Amber Shimpa (45 yo)

less than a year

Tenure

US$424,237

Compensatie

Ms. Amber H. Shimpa served as President of Vireo Growth Inc. (formerly known as Goodness Growth Holdings, Inc.) since February 2023 until October 10, 2024 and had been its Corporate Secretary until October...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Kyle Kingsley	Founder & Executive Chairman	10.3yrs	US$957.43k	2.6% CA$ 3.0m
Amber Shimpa	Chief Executive Officer	less than a year	US$424.24k	0.35% CA$ 401.0k
Joe Duxbury	Interim CFO and VP of Finance & IR	less than a year	geen gegevens	0.0012% CA$ 1.4k
Brendan Sweeny	Executive Vice President of Operations	less than a year	geen gegevens	geen gegevens
Eric Greenbaum	Chief Scientific Officer	3.8yrs	geen gegevens	geen gegevens
Nicole Stanton	Outside General Counsel	no data	geen gegevens	geen gegevens
Aaron Garrido	VP & Chief of Staff	less than a year	geen gegevens	geen gegevens
Brandon Van Asten	VP of Finance & Controller	less than a year	geen gegevens	geen gegevens

0.5yrs

Gemiddelde duur

45yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van VREO wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.5 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Kyle Kingsley	Founder & Executive Chairman	10.3yrs	US$957.43k	2.6% CA$ 3.0m
Judd Nordquist	Independent Director	5.7yrs	US$71.00k	0% CA$ 0
Victor Mancebo	Independent Director	3.8yrs	US$71.00k	0% CA$ 0
Ross Hussey	Independent Director	4.4yrs	US$71.00k	0.67% CA$ 770.0k

5.0yrs

Gemiddelde duur

46.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van VREO wordt beschouwd als ervaren (gemiddelde ambtstermijn 5 jaar).

Vireo Growth Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Vireo Growth Inc. Announces CFO Changes

Vireo Growth Inc. Announces Resignation of Josh Rosen as Director

Insufficient new directors

Goodness Growth Holdings, Inc. Appoints Josh Rosen as Chief Executive Officer

Goodness Growth Holdings, Inc., Annual General Meeting, Jun 21, 2024

Goodness Growth Holdings, Inc. Announces Departure of Michael Schroeder as General Counsel & Chief Compliance Officer Effective December 15, 2023

Recent updates

Third quarter 2024 earnings released: US$0.024 loss per share (vs US$0.037 loss in 3Q 2023)

Vireo Growth Inc. announced that it expects to receive $10 million in funding

Vireo Growth Inc. to Report Q3, 2024 Results on Nov 13, 2024

New minor risk - Market cap size

Vireo Growth Inc.'s (CSE:VREO) 29% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Vireo Growth Inc. Announces CFO Changes

Vireo Growth Inc. Announces Resignation of Josh Rosen as Director

Insufficient new directors

New major risk - Shareholder dilution

Vireo Growth Inc. announced that it has received $5.3875 million in funding

Vireo Growth Inc. (CSE:VREO) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Second quarter 2024 earnings released: US$0.005 loss per share (vs US$0.057 loss in 2Q 2023)

Vireo Growth Inc. to Report Q2, 2024 Results on Aug 06, 2024

Market Might Still Lack Some Conviction On Goodness Growth Holdings, Inc. (CSE:GDNS) Even After 30% Share Price Boost

Goodness Growth Holdings, Inc. announced that it expects to receive $0.7 million in funding

First quarter 2024 earnings released: US$0.047 loss per share (vs US$0.066 loss in 1Q 2023)

Goodness Growth Holdings, Inc. Appoints Josh Rosen as Chief Executive Officer

Goodness Growth Holdings, Inc. to Report Q1, 2024 Results on May 07, 2024

Goodness Growth Holdings, Inc., Annual General Meeting, Jun 21, 2024

Goodness Growth Holdings, Inc. (CSE:GDNS) Stock Rockets 30% But Many Are Still Ignoring The Company

Goodness Growth Holdings, Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023

Full year 2023 earnings released: US$0.19 loss per share (vs US$0.33 loss in FY 2022)

Goodness Growth Holdings, Inc. to Report Q4, 2023 Results on Mar 28, 2024

Investors Still Aren't Entirely Convinced By Goodness Growth Holdings, Inc.'s (CSE:GDNS) Revenues Despite 59% Price Jump

Goodness Growth Holdings, Inc. Announces Departure of Michael Schroeder as General Counsel & Chief Compliance Officer Effective December 15, 2023

Third quarter 2023 earnings released: US$0.037 loss per share (vs US$0.066 loss in 3Q 2022)

Goodness Growth Holdings, Inc. to Report Q3, 2023 Results on Nov 14, 2023

Goodness Growth Holdings, Inc. Announces CFO Changes

New major risk - Financial position

Second quarter 2023 earnings released: US$0.084 loss per share (vs US$0.048 loss in 2Q 2022)

Goodness Growth Holdings, Inc. to Report Q2, 2023 Results on Aug 14, 2023

New minor risk - Shareholder dilution

First quarter 2023 earnings released: US$0.066 loss per share (vs US$0.11 loss in 1Q 2022)

Goodness Growth Holdings, Inc. to Report Q1, 2023 Results on May 15, 2023

Goodness Growth Holdings, Inc. Announces Management Changes

Price target decreased to CA$0.85

Goodness Growth Holdings, Inc. Announces Departure of Christian Gonzalez-Ocasio as Chief Operating Officer

Goodness Growth Holdings, Inc Appoints Josh Rosen to the Role of Interim President

Goodness Growth Holdings, Inc. to Report Q3, 2022 Results on Nov 14, 2022

Goodness Growth Holdings, Inc., Annual General Meeting, Nov 18, 2022

Goodness Growth Holdings, Inc. Announces Launch of Boundary Waters Pre-Rolls in Minnesota

Second quarter 2022 earnings released: US$0.048 loss per share (vs US$0.044 loss in 2Q 2021)

Goodness Growth Holdings, Inc. Announces Unaudited and Condensed Impairment Results for the Quarter Ended June 30, 2022

Goodness Growth Holdings, Inc. Launches Cannabis-Infused Gummies in Minnesota

Goodness Growth Holdings Launches Hicolor™ Cannabis Chews in New York

First quarter 2022 earnings released: US$0.11 loss per share (vs US$0.059 loss in 1Q 2021)

Goodness Growth Holdings, Inc. Reports Consolidated Impairment of Long-Lived Assets for the Three Months Ended March 31, 2022

Price target increased to CA$4.00

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Price target increased to CA$4.00

Verano Holdings Corp. (CNSX:VRNO) entered into a definitive arrangement to acquire Goodness Growth Holdings, Inc. (CNSX:GDNS) for approximately $300 million.

Goodness Growth Holdings (CSE:GDNS) Is Carrying A Fair Bit Of Debt

Goodness Growth Holdings Launches New Line of Cannabis Edibles

Third quarter 2021 earnings released: US$0.078 loss per share (vs US$0.004 loss in 3Q 2020)

Price target decreased to CA$4.00

Goodness Growth Holdings, Inc. Retail Brand Green Goods® to Offer Medical Cannabis Program Information & Discounts At the Minnesota State Fair

Second quarter 2021 earnings released: US$0.044 loss per share (vs US$0.16 loss in 2Q 2020)

Health Check: How Prudently Does Goodness Growth Holdings (CSE:GDNS) Use Debt?

Goodness Growth Holdings Subsidiary Resurgent Biosciences Announces Planned Expansion into Psychedelics Research and Ip Development

Vireo Health International, Inc. Provides Revenue Guidance for the Fiscal Year 2022

First quarter 2021 earnings released: US$0.062 loss per share (vs US$0.076 loss in 1Q 2020)

Vireo Health Expands Ground Cannabis Flower in New York, Offers Largest Selection of Ground Flower At Any New York Dispensary

Insider recently sold CA$4.6m worth of stock

Full year 2020 earnings released: US$0.23 loss per share (vs US$0.67 loss in FY 2019)

Is Vireo Health International (CSE:VREO) Weighed On By Its Debt Load?

Vireo Health International, Inc. to Report Q4, 2020 Results on Mar 25, 2021

New 90-day high: CA$3.77

Did Business Growth Power Vireo Health International's (CSE:VREO) Share Price Gain of 127%?

Vireo Health International Inc. Appoints Victor E. Mancebo to its Board of Directors